FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897283235> ?p ?o ?g. }

• W2897283235 endingPage "627" @default.
• W2897283235 startingPage "621" @default.
• W2897283235 abstract "Recent data and National Comprehensive Cancer Network (NCCN) guidelines suggest that high-risk prostate cancer (cT3-4, Gleason score ≥8, or prostate-specific antigen [PSA] >20 ng/mL) is a heterogenous group in terms of long-term patient outcomes. We sought to determine whether subclassification of high-risk prostate cancer based on clinical factors correlates with genomic markers of risk.We identified 3220 patients with NCCN unfavorable intermediate-risk (n = 2000) or high-risk (n = 1220) prostate cancer from a prospective multi-institutional registry cohort. We defined the following subclassification of high-risk prostate cancer based on previously published data: favorable high risk (cT1c, Gleason 6, and PSA >20 ng/mL or cT1c, Gleason 4 + 4 = 8, PSA <10 ng/mL); very high risk (cT3b-T4 or primary Gleason pattern 5); and standard high risk (all others with cT3a, Gleason score ≥8, or PSA >20 ng/mL). We used a set of 33 previously developed genomic classifiers, including Decipher, to determine whether high-risk genomic features correlate with clinical subclasses of high-risk prostate cancer.Among those with favorable high-risk, standard high-risk, and very high-risk prostate cancer, 50.4%, 64.2%, and 81.6% had a high-risk Decipher score, respectively (P < .001). Among 32 other genomic signatures, 29 had a similar trend of increasing risk scores across the 3 subclasses of high-risk disease (P < .05 after correction for multiple hypothesis testing). Patients in the 3 subclasses of high-risk disease had a median of 4, 6, and 13 high-risk signatures, respectively. In comparison, among those with unfavorable intermediate-risk prostate cancer, 38.2% had a high-risk Decipher score, and the median number of high-risk signatures was 3.Although NCCN guidelines currently use a 2-tiered system for high-risk prostate cancer, genomic markers of risk correlate with the clinically validated subclassification of high-risk prostate cancer into favorable high-risk, standard high-risk, and very high-risk disease, further confirming the prognostic utility of this 3-tiered stratification." @default.
• W2897283235 created "2018-10-26" @default.
• W2897283235 creator A5001077235 @default.
• W2897283235 creator A5008974264 @default.
• W2897283235 creator A5014582211 @default.
• W2897283235 creator A5015096941 @default.
• W2897283235 creator A5017800332 @default.
• W2897283235 creator A5020006331 @default.
• W2897283235 creator A5044221282 @default.
• W2897283235 creator A5073123534 @default.
• W2897283235 creator A5073246821 @default.
• W2897283235 creator A5076238068 @default.
• W2897283235 creator A5083481623 @default.
• W2897283235 date "2019-11-01" @default.
• W2897283235 modified "2023-10-02" @default.
• W2897283235 title "Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate Cancer" @default.
• W2897283235 cites W1508662657 @default.
• W2897283235 cites W1565040574 @default.
• W2897283235 cites W1607198229 @default.
• W2897283235 cites W1824496400 @default.
• W2897283235 cites W1895094637 @default.
• W2897283235 cites W1967990571 @default.
• W2897283235 cites W1972298018 @default.
• W2897283235 cites W1972747451 @default.
• W2897283235 cites W1976359085 @default.
• W2897283235 cites W1990786792 @default.
• W2897283235 cites W1998343146 @default.
• W2897283235 cites W1999687329 @default.
• W2897283235 cites W2000056288 @default.
• W2897283235 cites W2018391923 @default.
• W2897283235 cites W2032739457 @default.
• W2897283235 cites W2042008553 @default.
• W2897283235 cites W2064042294 @default.
• W2897283235 cites W2064159164 @default.
• W2897283235 cites W2083763767 @default.
• W2897283235 cites W2088592436 @default.
• W2897283235 cites W2092868756 @default.
• W2897283235 cites W2100253170 @default.
• W2897283235 cites W2113962581 @default.
• W2897283235 cites W2114588641 @default.
• W2897283235 cites W2118136541 @default.
• W2897283235 cites W2122861585 @default.
• W2897283235 cites W2125516267 @default.
• W2897283235 cites W2126245040 @default.
• W2897283235 cites W2128613144 @default.
• W2897283235 cites W2133266067 @default.
• W2897283235 cites W2148497849 @default.
• W2897283235 cites W2151494814 @default.
• W2897283235 cites W2154557000 @default.
• W2897283235 cites W2159400887 @default.
• W2897283235 cites W2166666333 @default.
• W2897283235 cites W2262087934 @default.
• W2897283235 cites W2292362441 @default.
• W2897283235 cites W2330317483 @default.
• W2897283235 cites W2339393666 @default.
• W2897283235 cites W2408089991 @default.
• W2897283235 cites W2510843544 @default.
• W2897283235 cites W2519140831 @default.
• W2897283235 cites W2527710846 @default.
• W2897283235 cites W2601335591 @default.
• W2897283235 cites W2768353180 @default.
• W2897283235 cites W2769578203 @default.
• W2897283235 cites W2781525129 @default.
• W2897283235 cites W2807317262 @default.
• W2897283235 doi "https://doi.org/10.1016/j.ijrobp.2019.06.2510" @default.
• W2897283235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31271825" @default.
• W2897283235 hasPublicationYear "2019" @default.
• W2897283235 type Work @default.
• W2897283235 sameAs 2897283235 @default.
• W2897283235 citedByCount "8" @default.
• W2897283235 countsByYear W28972832352019 @default.
• W2897283235 countsByYear W28972832352020 @default.
• W2897283235 countsByYear W28972832352021 @default.
• W2897283235 countsByYear W28972832352023 @default.
• W2897283235 crossrefType "journal-article" @default.
• W2897283235 hasAuthorship W2897283235A5001077235 @default.
• W2897283235 hasAuthorship W2897283235A5008974264 @default.
• W2897283235 hasAuthorship W2897283235A5014582211 @default.
• W2897283235 hasAuthorship W2897283235A5015096941 @default.
• W2897283235 hasAuthorship W2897283235A5017800332 @default.
• W2897283235 hasAuthorship W2897283235A5020006331 @default.
• W2897283235 hasAuthorship W2897283235A5044221282 @default.
• W2897283235 hasAuthorship W2897283235A5073123534 @default.
• W2897283235 hasAuthorship W2897283235A5073246821 @default.
• W2897283235 hasAuthorship W2897283235A5076238068 @default.
• W2897283235 hasAuthorship W2897283235A5083481623 @default.
• W2897283235 hasConcept C11783203 @default.
• W2897283235 hasConcept C121608353 @default.
• W2897283235 hasConcept C12174686 @default.
• W2897283235 hasConcept C126322002 @default.
• W2897283235 hasConcept C143998085 @default.
• W2897283235 hasConcept C164614171 @default.
• W2897283235 hasConcept C188816634 @default.
• W2897283235 hasConcept C2776235491 @default.
• W2897283235 hasConcept C2779134260 @default.
• W2897283235 hasConcept C2780192828 @default.
• W2897283235 hasConcept C2781406297 @default.
• W2897283235 hasConcept C29456083 @default.

• next